Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Oppenheimer Holdings (OPY) Research & Development (2016 - 2025)

Oppenheimer Holdings' Research & Development history spans 16 years, with the latest figure at $27.4 million for Q4 2025.

  • For Q4 2025, Research & Development rose 7.63% year-over-year to $27.4 million; the TTM value through Dec 2025 reached $105.8 million, up 6.45%, while the annual FY2025 figure was $105.8 million, 6.45% up from the prior year.
  • Research & Development for Q4 2025 was $27.4 million at Oppenheimer Holdings, up from $25.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $27.4 million in Q4 2025 and bottomed at $19.2 million in Q2 2021.
  • The 5-year median for Research & Development is $22.7 million (2023), against an average of $23.1 million.
  • The largest annual shift saw Research & Development decreased 10.09% in 2021 before it increased 9.52% in 2024.
  • A 5-year view of Research & Development shows it stood at $21.0 million in 2021, then grew by 2.24% to $21.5 million in 2022, then increased by 9.38% to $23.5 million in 2023, then rose by 8.48% to $25.5 million in 2024, then increased by 7.63% to $27.4 million in 2025.
  • Per Business Quant, the three most recent readings for OPY's Research & Development are $27.4 million (Q4 2025), $25.9 million (Q3 2025), and $26.2 million (Q2 2025).